Global Ischemic Optic Neuropathy Treatment Market Size study, by Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), and Regional Forecasts 2021-2027

BIZ4595115
200 Pages
June 2021
Pharmaceuticals

Download Sample Get Discount

Global Ischemic Optic Neuropathy Treatment Market is valued at approximately USD XX million in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. There are two forms of ischemic optic neuropathies (IONs): posterior ischemic optic neuropathy (PION) and anterior ischemic optic neuropathy (AION). Anterior ischemic optic neuropathy (AION) is caused by inflammation of the arteries that feed blood to the optic nerve, while non-anterior ischemic optic neuropathy is caused by other factors. Individuals are more likely to develop anterior ischemic optic neuropathy than posterior ischemic optic neuropathy. In the case of anterior ischemic optic neuropathy, immediate treatment is required to prevent vision loss in the affected eye, as it can also cause damage to the other eye in as little as 5 to 10 days. As the number of people with optic nerve problems rises, so does interest in the pharmaceuticals that treat them, supporting market growth. According to the World Health Organization (WHO), over 1.3 billion people suffer from eyesight problems. In the optometric area, growing interest in non-invasive medical procedures is also creating attractive prospects for industry players. Patients, after learning about the costs and hazards of surgeries, have a strong preference for pharmaceuticals over medical procedures, which is a major component in the market's growth. Several key manufacturers are taking strategic initiatives to expand their presence in the market. For instance, in January 2021, Eli Lilly and Company acquired Prevail Therapeutics Inc. establishing a new mode of medication discovery and development. Similarly, The Brazilian Health Regulatory Agency (ANVISA - Agência Nacional de Vigilância Sanitária) approved Bausch Health Companies Inc.'s VYZULTA (latanoprostene bunod ophthalmic solution), 0.024 percent, in April 2021. Likewise, Teva Pharmaceuticals announced a new strategic focus on the Japanese market in July 2020. Specialty assets and a portfolio of select generics that fulfil patients' medical needs are the focus of Japan's commercial endeavour. However, side effects associated with the treatment may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Ischemic Optic Neuropathy Treatment Market is considered for the key regions such as North America, Asia Pacific, Latin America, Europe, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to high availability of advanced treatment facilities and medical infrastructure in the region. Whereas Europe is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to R&D activities in the treatment of eye-related diseases.

Major market player included in this report are:

AbbVie Inc.

Eli Lily Company

GlaxoSmithKline

Pfizer Inc.

Teva Pharmaceuticals

Bausch Health Companies Inc.

F. Hoffmann-La Roche AG

Bayer AG

Sanofi A.S.

Bristol-Myers Squibb and Company

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

Steroidal Therapy

Immunomodulators therapy

Other Treatment Types

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018-19

Base year – 2019-2020

Forecast period – 2021 to 2027.

Target Audience of the Global Ischemic Optic Neuropathy Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Ischemic Optic Neuropathy Treatment Market, by Region, 2019-2027 (USD Billion)

1.2.2. Ischemic Optic Neuropathy Treatment Market, by Treatment Type, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Ischemic Optic Neuropathy Treatment Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Ischemic Optic Neuropathy Treatment Market Dynamics

3.1. Ischemic Optic Neuropathy Treatment Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increasing prevalence of optic neuritis

3.1.1.2. Favourable reimbursement policies

3.1.2. Market Restraint

3.1.2.1. Side effects associated with the treatment

3.1.3. Market Opportunities

3.1.3.1. Availability of reimbursement

3.1.3.2. Growing awareness among the population

Chapter 4. Global Ischemic Optic Neuropathy Treatment Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Ischemic Optic Neuropathy Treatment Market, by Treatment Type

5.1. Market Snapshot

5.2. Global Ischemic Optic Neuropathy Treatment Market by Treatment Type , Performance - Potential Analysis

5.3. Global Ischemic Optic Neuropathy Treatment Market Estimates & Forecasts by Treatment Type 2018-2027 (USD Billion)

5.4. Ischemic Optic Neuropathy Treatment Market, Sub Segment Analysis

5.4.1. Steroidal Therapy

5.4.2. Immunomodulators therapy

5.4.3. Other Treatment Types

Chapter 6. Global Ischemic Optic Neuropathy Treatment Market, Regional Analysis

6.1. Ischemic Optic Neuropathy Treatment Market, Regional Market Snapshot

6.2. North America Ischemic Optic Neuropathy Treatment Market

6.2.1. U.S. Ischemic Optic Neuropathy Treatment Market

6.2.1.1. Treatment Type breakdown estimates & forecasts, 2018-2027

6.2.2. Canada Ischemic Optic Neuropathy Treatment Market

6.3. Europe Ischemic Optic Neuropathy Treatment Market Snapshot

6.3.1. U.K. Ischemic Optic Neuropathy Treatment Market

6.3.2. Germany Ischemic Optic Neuropathy Treatment Market

6.3.3. France Ischemic Optic Neuropathy Treatment Market

6.3.4. Spain Ischemic Optic Neuropathy Treatment Market

6.3.5. Italy Ischemic Optic Neuropathy Treatment Market

6.3.6. Rest of Europe Ischemic Optic Neuropathy Treatment Market

6.4. Asia-Pacific Ischemic Optic Neuropathy Treatment Market Snapshot

6.4.1. China Ischemic Optic Neuropathy Treatment Market

6.4.2. India Ischemic Optic Neuropathy Treatment Market

6.4.3. Japan Ischemic Optic Neuropathy Treatment Market

6.4.4. Australia Ischemic Optic Neuropathy Treatment Market

6.4.5. South Korea Ischemic Optic Neuropathy Treatment Market

6.4.6. Rest of Asia Pacific Ischemic Optic Neuropathy Treatment Market

6.5. Latin America Ischemic Optic Neuropathy Treatment Market Snapshot

6.5.1. Brazil Ischemic Optic Neuropathy Treatment Market

6.5.2. Mexico Ischemic Optic Neuropathy Treatment Market

6.6. Rest of The World Ischemic Optic Neuropathy Treatment Market

Chapter 7. Competitive Intelligence

7.1. Top Market Strategies

7.2. Company Profiles

7.2.1. AbbVie Inc.

7.2.1.1. Key Information

7.2.1.2. Overview

7.2.1.3. Financial (Subject to Data Availability)

7.2.1.4. Product Summary

7.2.1.5. Recent Developments

7.2.2. Eli Lily Company

7.2.3. GlaxoSmithKline

7.2.4. Pfizer Inc.

7.2.5. Teva Pharmaceuticals

7.2.6. Bausch Health Companies Inc.

7.2.7. F. Hoffmann-La Roche AG

7.2.8. Bayer AG

7.2.9. Sanofi A.S.

7.2.10. Bristol-Myers Squibb and Company

Chapter 8. Research Technology

8.1. Research Technology

8.1.1. Data Mining

8.1.2. Analysis

8.1.3. Market Estimation

8.1.4. Validation

8.1.5. Publishing

8.2. Research Attributes

8.3. Research Assumption

List of Tables

TABLE 1. Global Ischemic Optic Neuropathy Treatment Market, report scope

TABLE 2. Global Ischemic Optic Neuropathy Treatment Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 3. Global Ischemic Optic Neuropathy Treatment Market estimates & forecasts by Treatment Type 2018-2027 (USD Billion)

TABLE 4. Global Ischemic Optic Neuropathy Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 5. Global Ischemic Optic Neuropathy Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 6. Global Ischemic Optic Neuropathy Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Ischemic Optic Neuropathy Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Ischemic Optic Neuropathy Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Ischemic Optic Neuropathy Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Ischemic Optic Neuropathy Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Ischemic Optic Neuropathy Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Ischemic Optic Neuropathy Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Ischemic Optic Neuropathy Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Ischemic Optic Neuropathy Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Ischemic Optic Neuropathy Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Ischemic Optic Neuropathy Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Ischemic Optic Neuropathy Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Ischemic Optic Neuropathy Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Global Ischemic Optic Neuropathy Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. U.S. Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. U.S. Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 22. U.S. Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. Canada Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 24. Canada Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. Canada Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. UK Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 27. UK Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. UK Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. Germany Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 30. Germany Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. Germany Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. France Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 33. France Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. France Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. Spain Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 36. Spain Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. Spain Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Italy Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 39. Italy Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. Italy Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. ROE Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 42. ROE Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. ROE Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. China Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 45. China Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. China Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. India Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 48. India Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. India Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. Japan Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 51. Japan Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. Japan Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Australia Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 54. Australia Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. Australia Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. South Korea Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 57. South Korea Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 58. South Korea Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 59. ROPAC Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 60. ROPAC Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 61. ROPAC Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 62. Brazil Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 63. Brazil Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 64. Brazil Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 65. Mexico Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 66. Mexico Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 67. Mexico Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 68. ROLA Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 69. ROLA Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 70. ROLA Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 71. ROW Ischemic Optic Neuropathy Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 72. ROW Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 73. ROW Ischemic Optic Neuropathy Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 74. List of secondary sources used in the study of global Ischemic Optic Neuropathy Treatment Market.

TABLE 75. List of primary sources used in the study of global Ischemic Optic Neuropathy Treatment Market.

TABLE 76. Years considered for the study.

TABLE 77. Exchange rates considered.

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Ischemic Optic Neuropathy Treatment Market Size study, by Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), and Regional Forecasts 2021-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara